跳至主要内容
临床试验/EUCTR2008-005078-10-IT
EUCTR2008-005078-10-IT进行中(未招募)不适用

RANDOMISED, OPEN-LABEL CLINICAL TRIAL ON THE EFFICACY OF COLISTIN PLUS RIFAMPICIN TREATMENT VERSUS COLISTIN ALONE FOR SEVERE INFECTIONS BY MULTIDRUG-RESISTANT ACINETOBACTER BAUMANNII - COLISTIN AND RIFAMPICIN FOR MDR-ACINETOBACTER

AZIENDA OSPEDALIERA VINCENZO MONALDI DI NAPOLI0 个研究点开始时间: 2008年12月11日最近更新:

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Microbiological evidence of severe infection due to multi-drug resistant A. baumannii during hospitalization, with susceptibility of the isolate to colistin (MIC 2 mg/l), irrespective of the susceptibility to rifampicin.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Exclusion criteria will be as follows: age below 18 years; treatment with one of the study drugs prior to the diagnosis of A. baumannii infection; severe liver dysfunction; history of prior hypersensitivity to the study drugs.

研究者

发起方
AZIENDA OSPEDALIERA VINCENZO MONALDI DI NAPOLI

相似试验

RANDOMISED, OPEN-LABEL CLINICAL TRIAL ON THE... | 临床试验